The company voluntarily ordered the Class 1 recall, meaning the products could pose an imminent hazard to health in patients, on Sept. 14.
Synthes said it took action after receiving six reports of patients suffering moderate to severe symptoms 6-15 months after implantation.
Read the release on Synthes’ recall of Synex II Central Body components.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
